United Therapeutics (UTHR) reported 677.7millioninrevenueforthequarterendedMarch2024,representingayear−over−yearincreaseof33.76.17 for the same period compares to 4.86ayearago.Thereportedrevenuerepresentsasurpriseof+7.96627.72 million. With the consensus EPS estimate being $5.63, the EPS surprise was +9.59%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to ...